+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opiant Pharmaceuticals Inc - logo

Opiant Pharmaceuticals is a specialty pharmaceutical company that develops opioid antagonist treatments for addictions and related disorders. The company’s portfolio includes NARCAN nasal spray, a treatment to reverse opioid overdoses. It is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa. Formerly known as Lightlake Therapeutics, it changed its name in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.

From
Opioid Related Disorder - Pipeline Insight, 2021 - Product Thumbnail Image

Opioid Related Disorder - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 80 Pages
  • Global
From
Addictions Therapeutics Global Market Report 2023 - Product Thumbnail Image

Addictions Therapeutics Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
From
Opium (Opioid) Addiction - Pipeline Review, H2 2020 - Product Thumbnail Image

Opium (Opioid) Addiction - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 193 Pages
  • Global
From
From
Alcohol Use Disorder Treatment Pipeline Analysis 2019 (H1) - Product Thumbnail Image

Alcohol Use Disorder Treatment Pipeline Analysis 2019 (H1)

  • Report
  • May 2019
  • 109 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2020 - Product Thumbnail Image

Alcohol Use Disorder - Pipeline Insight, 2020

  • Clinical Trials
  • October 2020
  • 90 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2021 - Product Thumbnail Image

Cocaine Use Disorder - Pipeline Insight, 2021

  • Clinical Trials
  • January 2021
  • 60 Pages
  • Global
From
Loading Indicator